Johanna Krüger

ORCID: 0000-0003-4346-1133
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Amyotrophic Lateral Sclerosis Research
  • Multiple Sclerosis Research Studies
  • Neuroscience and Neuropharmacology Research
  • Parkinson's Disease Mechanisms and Treatments
  • Genetic Neurodegenerative Diseases
  • Ion channel regulation and function
  • Epilepsy research and treatment
  • Genetics, Bioinformatics, and Biomedical Research
  • Cardiac electrophysiology and arrhythmias
  • Mitochondrial Function and Pathology
  • Functional Brain Connectivity Studies
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Genomics and Rare Diseases
  • Neurogenetic and Muscular Disorders Research
  • Neurological diseases and metabolism
  • Cognitive Functions and Memory
  • Cerebrospinal fluid and hydrocephalus
  • Genetics and Neurodevelopmental Disorders
  • Neurological disorders and treatments
  • Craniofacial Disorders and Treatments
  • Polyomavirus and related diseases
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Diet and metabolism studies

Oulu University Hospital
2011-2025

University of Oulu
2012-2025

University of Brescia
2024

University of Pavia
2024

Northern Ostrobothnia Hospital District
2019-2024

University of Eastern Finland
2024

Hertie Institute for Clinical Brain Research
2021-2023

University of Tübingen
2021-2023

Kiel University
2022-2023

University of Potsdam
2020

<h3>Objectives</h3> To study the safety and efficacy of vitamin D3 as an add on therapy to interferon β-1b (IFNB) in patients with multiple sclerosis (MS). <h3>Methods</h3> 1 year, double blind, placebo controlled, randomised 66 MS patients. The primary outcomes were T2 burden disease (BOD) MRI scans, proportion serum levels 25-hydroxyvitamin D (25(OH)D) ≥85 nmol/l or intact parathyroid hormone (PTH) ≤20 ng/l, number adverse events. Secondary enhancing T1 lesions new lesions, annual relapse...

10.1136/jnnp-2011-301876 article EN Journal of Neurology Neurosurgery & Psychiatry 2012-02-22
Katrine M. Johannesen Yuanyuan Liu Mahmoud Koko Cathrine E. Gjerulfsen Lukas Sonnenberg and 95 more Julian Schubert Christina Fenger Ahmed Eltokhi Maert Rannap Nils A. Koch Stephan Lauxmann Johanna Krüger Josua Kegele Laura Canafoglia Silvana Franceschetti Patrick May Johannes Rebstock Pia Zacher Susanne Ruf Michael Alber Katalin Štěrbová Petra Laššuthová Markéta Vlčková Johannes R. Lemke Konrad Platzer Ilona Krey Constanze Heine Dagmar Wieczorek Judith Kroell-Seger Caroline Lund Karl Martin Klein P Y Billie Au Jong M. Rho Alice Ho Silvia Masnada Pierangelo Veggiotti Lucio Giordano Patrizia Accorsi Christina E. Hoei‐Hansen Pasquale Striano Federico Zara Hélène Verhelst J. Verhoeven Hilde M. H. Braakman Bert van der Zwaag Aster V. E. Harder Eva H. Brilstra Manuela Pendziwiat Sebastian Lebon María Magdalena Vaccarezza Ngọc Minh Lê Jakob Christensen Sabine Grønborg Stephen W. Scherer Jennifer Howe Walid Fazeli Katherine B. Howell Richard J. Leventer Chloe Stutterd Sonja Walsh Marion Gérard Bénédicte Gerard Sara Matricardi Claudia Bonardi Stefano Sartori Andrea Berger Dorota Hoffman‐Zacharska Massimo Mastrangelo Francesca Darra Arve Vøllo M. Mahdi Motazacker Phillis Lakeman Mathilde Nizon Cornelia Betzler Cécilia Altuzarra Roseline Caume Agathe Roubertie Philippe Gélisse Carla Marini Renzo Guerrini Frédéric Bilan Daniel Tibussek Margarete Koch‐Hogrebe Μ. Scott Perry Shoji Ichikawa Е. Л. Дадали Artem Sharkov Irina Mishina M. O. Abramov Ilya V. Kanivets С. А. Коростелев Sergey I. Kutsev Karen E. Wain Nancy Eisenhauer Monisa Wagner Juliann M. Savatt Karen Müller‐Schlüter Haim Bassan Artem Borovikov Marie–Cécile Nassogne

Abstract We report detailed functional analyses and genotype-phenotype correlations in 392 individuals carrying disease-causing variants SCN8A, encoding the voltage-gated Na+ channel Nav1.6, with aim of describing clinical phenotypes related to effects. Six different subgroups were identified: Group 1, benign familial infantile epilepsy (n = 15, normal cognition, treatable seizures); 2, intermediate 33, mild intellectual disability, partially pharmaco-responsive); 3, developmental epileptic...

10.1093/brain/awab321 article EN Brain 2021-08-25

Diagnostic incidence data for syndromes associated with frontotemporal lobar degeneration (FTLD) in multinational studies are urgent light of upcoming therapeutic approaches.To assess the FTLD across Europe.The Frontotemporal Dementia Incidence European Research Study (FRONTIERS) was a retrospective cohort study conducted from June 1, 2018, to May 31, 2019, using population-based registry 13 tertiary research clinics UK, Netherlands, Finland, Sweden, Spain, Bulgaria, Serbia, Germany, and...

10.1001/jamaneurol.2022.5128 article EN cc-by-nc-nd JAMA Neurology 2023-01-30

Accumulation of amyloid-β is a key neuropathological feature in brain Alzheimer's disease patients. Alterations cerebral haemodynamics, such as arterial impulse propagation driving the (peri)vascular CSF flux, predict future progression. We now present non-invasive method to quantify three-dimensional cardiovascular impulses human using ultrafast 10 Hz magnetic resonance encephalography. This technique revealed spatio-temporal abnormalities disease. The arrival latency and speed both...

10.1093/brain/awab144 article EN cc-by Brain 2021-03-30

Abstract Biomarkers sensitive to prodromal or early pathophysiological changes in Alzheimer’s disease (AD) symptoms could improve detection and enable timely interventions. Changes brain hemodynamics may be associated with the main clinical AD symptoms. To test this possibility, we measured variability of blood oxygen level-dependent (BOLD) signal individuals from three independent datasets (totaling 80 patients 90 controls). We detected a replicable increase BOLD populations, which...

10.1038/s41598-020-77984-1 article EN cc-by Scientific Reports 2020-12-09

In this paper, a new concept of extra-durable and sustainable wind turbine blades is presented. The two critical materials science challenges the development energy now are necessity to prevent degradation for several decades, and, on other side, provide solution recyclability sustainability blades. preliminary studies by DTU Wind, it was demonstrated that practically all typical blade mechanisms (e.g., coating detachment, buckling, spar cap/shell adhesive joint degradation, trailing edge...

10.3390/biomimetics8060448 article EN cc-by Biomimetics 2023-09-22

Autoantibodies directed against the GluA3 subunit (anti-GluA3 hIgGs) of AMPA receptors have been identified in 20%–25% patients with frontotemporal lobar degeneration (FTLD). Data from and vitro/ex vivo pre-clinical studies indicate that anti-GluA3 hIgGs negatively affect glutamatergic neurotransmission. However, whether how chronic presence triggers synaptic dysfunctions appearance FTLD-related neuropathological behavioural signature has not clarified yet. To address this question, we...

10.1016/j.bbi.2024.03.018 article EN cc-by Brain Behavior and Immunity 2024-03-12

Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with various clinical and neuropathological subtypes. The two major pathological proteins accumulating in the brains FTD patients, depending on their genetic background, are TDP-43 tau. We aimed to evaluate whether total levels measured from serum associate genotype or phenotype patients provides prognostic diagnostic value disorders. study cohort included 254 participants diagnosis (including all genotypes...

10.1186/s13195-022-01091-8 article EN cc-by Alzheimer s Research & Therapy 2022-10-11

ABSTRACT Background The treatment of relapsing‐remitting multiple sclerosis (RRMS) is changing. There are limited data about initial RRMS in Finland. Objective Our objectives were to study the trends disease‐modifying treatments (DMTs) for patients with from 2013 2022, delays, factors associated DMT choice, switch patterns, and effect COVID‐19 pandemic. Methods This retrospective register used secondary Finnish MS register. DMTs classified into medium‐efficacy (meDMTs; beta interferons,...

10.1002/brb3.70326 article EN cc-by Brain and Behavior 2025-02-01

Alzheimer's disease (AD) is characterized by specific neuropathologies, and associated with arterial wall β-amyloid accumulations, which lead to radiologically detectable amplitude increases variable propagation speed of cardiovascular impulses in brain. In this study, we developed a fast frequency domain imaging method know as relative harmonic power magnetic resonance encephalography (MREG RHP ), aiming investigate the configuration independently mean signal intensity physiological impulse...

10.1101/2025.02.26.640409 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-03-02

ABSTRACT Introduction Literature on criminal behavior preceding a neurodegenerative disease diagnosis is insufficient. Some studies suggest increased crime rates among patients with frontotemporal dementia (FTD). Methods Patients diseases were gathered from Kuopio and Oulu University Hospitals compared nonselective general population data Statistics Finland ( N = 24,144). Clinical linked to the Finnish national register of police‐reported crimes. Results In total, 2424 participants included....

10.1111/ene.70134 article EN cc-by-nc-nd European Journal of Neurology 2025-04-01
Saira Saeed Mirza Maurice Pasternak Andrew D. Paterson Ekaterina Rogaeva Maria Carmela Tartaglia and 95 more Sara Mitchell Sandra E. Black Morris Freedman David F. Tang‐Wai Arabella Bouzigues Lucy L. Russell Phoebe H. Foster Eve Ferry‐Bolder Martina Bocchetta David M. Cash Henrik Zetterberg Aitana Sogorb‐Esteve John C. van Swieten Lize C. Jiskoot Harro Seelaar Raquel Sánchez‐Valle Robert Laforce Caroline Graff Daniela Galimberti Rik Vandenberghe Alexandre de Mendonça Pietro Tiraboschi Isabel Santana Alexander Gerhard Johannes Levin Sandro Sorbi Markus Otto Florence Pasquier Simon Ducharme Christopher Butler Isabelle Le Ber Elizabeth Finger James B. Rowe Matthis Synofzik Fermín Moreno Barbara Borroni Jonathan D. Rohrer Mario Masellis Rhian S. Convery Sophie Goldsmith Kiran Samra David L. Thomas Thomas Cope Timothy Rittman Maura Malpetti Antonella Alberici Enrico Premi Roberto Gasparotti Emanuele Buratti Valentina Cantoni Andrea Arighi Chiara Fenoglio Vittoria Borracci María Serpente Tiziana Carandini Emanuela Rotondo Giacomina Rossi Giorgio Giaccone Giuseppe Di Fede Paola Caroppo Sara Prioni Veronica Redaelli Johanna Krüger Miguel Castelo-Branco Ron Keren Christen Shoesmith Robert Bartha Rosa Rademakers Jackie M. Poos Janne M. Papma Lucia Giannini Liset de Boer Jan De Houwer Rick van Minkelen Yolande A.L. Pijnenburg Benedetta Nacmias Camilla Ferrari Cristina Polito Gemma Lombardi Valentina Bessi Enrico Fainardi Stefano Chiti Mattias Nilsson Henrik Viklund Melissa Taheri Rydell Vesna Jelić Linn Öijerstedt Tobias Langheinrich Albert Lladó Anna Antonell Jaume Olives Mircea Balasa Núria Bargalló Sergi Borrego‐Écija Ana Verdelho

Abstract Common variants within TMEM106B are associated with risk for frontotemporal lobar degeneration TDP-43 pathology (FTLD-TDP). The G allele of the top single nucleotide polymorphism, rs1990622, confers protection against FTLD-TDP, including genetic cases due to GRN mutations or C9orf72 hexanucleotide repeat expansions. However, effects interaction between TMEM106B-rs1990622 and dementia (FTD) on disease endophenotypes in FTD unknown. This longitudinal cohort study was embedded GENetic...

10.1093/brain/awaf019 article EN Brain 2025-04-22

Abstract Biallelic loss-of-function variants in TYROBP and TREM2 cause autosomal recessive presenile dementia with bone cysts known as Nasu-Hakola disease (NHD, alternatively polycystic lipomembranous osteodysplasia sclerosing leukoencephalopathy, PLOSL). Some other contribute to the risk of Alzheimer’s (AD) frontotemporal dementia, while deleterious are globally extremely rare their role neurodegenerative diseases remains unclear. The population history Finns has favored enrichment founder...

10.1186/s13024-025-00830-3 article EN cc-by Molecular Neurodegeneration 2025-04-29

ABSTRACT Extracellular vesicles (EVs), nanoparticles secreted by both gram-negative and gram-positive bacteria, carry various biomolecules cross biological barriers. Gut microbiota-derived EVs are currently being investigated as a communication mechanism between the microbiota host. Few clinical studies, however, have gut EVs. Here, we show that machine learning models were able to accurately distinguish respective EV samples according their taxonomic composition within each data set (area...

10.1128/msystems.00311-25 article EN cc-by mSystems 2025-04-29

Abstract Background Frontotemporal lobar degeneration (FTLD) consists of a clinically and neuropathologically heterogeneous group syndromes affecting the frontal temporal lobes brain. Mutations in microtubule-associated protein tau ( MAPT ), progranulin PGRN ) charged multi-vesicular body 2B CHMP2B are associated with familial forms disease. The prevalence these mutations varies between populations. H1 haplotype has been found to be closely tauopathies sporadic FTLD. Our aim was investigate...

10.1186/1471-2377-8-48 article EN cc-by BMC Neurology 2008-12-01

<h3>Objective:</h3> We describe the neurologic, neuroradiologic, and ophthalmologic phenotype of 1 Swedish Finnish family with autosomal dominant ataxia-pancytopenia (ATXPC) syndrome <i>SAMD9L</i> mutations. <h3>Methods:</h3> Members these families germline c.2956C&gt;T, p.Arg986Cys, or c.2672T&gt;C, p.Ile891Thr mutations underwent structured interviews neurologic examinations. Neuroimaging was performed, medical records were reviewed. Previous publications on <i>SAMD9L</i>-ATXPC...

10.1212/nxg.0000000000000183 article EN cc-by-nc-nd Neurology Genetics 2017-08-25

De novo missense variants in KCNQ5, encoding the voltage-gated K+ channel KV7.5, have been described to cause developmental and epileptic encephalopathy (DEE) or intellectual disability (ID). We set out identify disease-related KCNQ5 genetic generalized epilepsy (GGE) their underlying mechanisms.1292 families with GGE were studied by next-generation sequencing. Whole-cell patch-clamp recordings, biotinylation phospholipid overlay assays performed mammalian cells combined homology...

10.1016/j.ebiom.2022.104244 article EN cc-by EBioMedicine 2022-09-09

Abstract Biallelic loss-of-function variants in TYROBP and TREM2 cause autosomal recessive presenile dementia with bone cysts known as Nasu-Hakola disease (NHD, alternatively polycystic lipomembranous osteodysplasia sclerosing leukoencephalopathy, PLOSL). Some other contribute to the risk of Alzheimer’s (AD) frontotemporal dementia, while deleterious are globally extremely rare their role neurodegenerative diseases remains unclear. The population history Finns has favored enrichment founder...

10.1101/2024.05.09.24307099 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-05-10

Mitochondrial dysfunction, oxidative damage and the accumulation of somatic mutations in mitochondrial DNA (mtDNA) have been associated with certain neurodegenerative disorders. Previous studies also provided controversial results on association mtDNA haplogroups susceptibility to Alzheimer's disease (AD), but possible relationships between frontotemporal lobar degeneration (FTLD) less frequently studied.We analysed role its maintenance enzymes 128 early-onset AD (eoAD) 66 FTLD cases....

10.1186/1750-1326-5-8 article EN cc-by Molecular Neurodegeneration 2010-02-02

Only a few studies have evaluated modifiable risk factors for frontotemporal dementia (FTD). Here, we several and their association with disease phenotype, genotype, prognosis in large study population including Finnish Italian patients FTD control groups.

10.1002/acn3.51619 article EN Annals of Clinical and Translational Neurology 2022-06-29

Background and purpose: Mutations in the progranulin ( PGRN ) gene have recently been associated with frontotemporal lobar degeneration (FTLD). The frequency of these mutations varies between populations. aim this study was to determine genetic variations Finnish patients FTLD motor neuron disease (FTLD‐MND). Subjects methods: All exons were sequenced from 69 FTLD. FTLD‐MND phenotype present 13 patients. Results: No pathogenic identified cohort. Eleven sequence detected, which IVS8 +...

10.1111/j.1468-1331.2008.02272.x article EN European Journal of Neurology 2008-11-25
Coming Soon ...